CollPlant Biotechnologies Ltd. filed a Form 6-K with the SEC on November 4, 2026, announcing a proposed name change to OptiPhi Computing Ltd., reflecting the company's stated expansion into computing with light.

Key Highlights

  • Proposed name change: CollPlant Biotechnologies Ltd. announced a proposal to rename the company OptiPhi Computing, according to the filing.
  • Strategic direction: The proposed name change is described in the filing as "Reflecting Expansion to Computing with Light."
  • Press release date: The company issued the press release on November 4, 2026.
  • Incorporated into registration statements: The first two paragraphs of the press release were incorporated by reference into the company's Registration Statements on Form S-8 (File Nos. 333-229163, 333-248479, 333-263842, 333-271320, and 333-279791) and Form F-3 (File Nos. 333-238731, 333-292640, and 333-297347).
  • Signatory: The filing was signed by Eran Rotem, identified as Chief Executive Officer and Chief Financial Officer.

CollPlant Biotechnologies Discloses Proposed Rebrand to OptiPhi Computing

According to the Form 6-K submitted to the SEC, CollPlant Biotechnologies Ltd. (NASDAQ:CLGN), a foreign private issuer headquartered at 4 Oppenheimer St, Weizmann Science Park, Rehovot 7670104, Israel, announced on November 4, 2026 that it is proposing to change its corporate name to OptiPhi Computing. The company described the rationale in the title of the press release as "Reflecting Expansion to Computing with Light," though no additional operational or financial details about this expansion were included in the body of the 6-K filing itself.

The filing notes that the first two paragraphs of the attached press release (Exhibit 99.1) were incorporated by reference into five active Form S-8 registration statements and three Form F-3 registration statements, effective from the date the report was submitted. CollPlant files annual reports under Form 20-F, as indicated on the cover page of the filing. The report was signed by Eran Rotem in his dual capacity as Chief Executive Officer and Chief Financial Officer.

The filing carries Commission File Number 001-38370 and was submitted pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, covering the month of November 2026. The substantive disclosure in the 6-K is limited to the name-change announcement; no financial results, projections, or additional business detail were included in the filing text.

What Was Disclosed

CollPlant Biotechnologies Ltd. filed a Form 6-K on November 4, 2026, disclosing a proposed corporate name change to OptiPhi Computing, citing expansion into computing with light. The press release was incorporated by reference into several active registration statements.